Download pdf Patients, family and donors invited to special bone marrow transplant event in Frankfurt
Download pdf EBMT receives a regulatory qualification from the European Medicine Agency (EMA) on the use of its patient registry to support novel CAR T-cell therapies. The EBMT registry has been qualified by EMA as a suitable platform for the collection of data for post-authorisation safety surveillance and efficacy studies.
Download pdf EMA qualification opinion on Cellular therapy module of the EBMT Registry EBMT requested qualification of the cellular therapy module of the EBMT Registry as suitable for performing pharmacoepidemiological studies for regulatory purposes, concerning CAR-T cell therapy for haematological malignancies.
Download pdf Role description of the EBMT Nurses Group Board President, President Elect, Secretary and Accounts officer.
Download pdf Consensus recommendations for the role and competencies of the European pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation This document presents the activities that should be performed by pharmacists and pharmacologists with the focus on pharmacotherapy and ensuring optimal medication-related outcomes from a European perspective.